2 Biotech Stocks to Buy After Earnings

By Louis Navellier, Editor, Blue Chip GrowthTwo of my favorite biotech companies reported third-quarter results today, and they did not disappoint. If you haven’t already picked them up, both of these stocks are solid “buys” at current prices.PLUS: 3 American Financial Stocks to BuyLet’s take a look…Actavis (ACT)Actavis (ACT) surpassed analysts’ sales and earnings expectations for the third quarter. Actavis reported […]